

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.75787832 |
| 2 | fucose catabolic process (GO:0019317) | 4.45414547 |
| 3 | L-fucose metabolic process (GO:0042354) | 4.45414547 |
| 4 | L-fucose catabolic process (GO:0042355) | 4.45414547 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 4.19554743 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.19401258 |
| 7 | protein-cofactor linkage (GO:0018065) | 4.18547391 |
| 8 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.17895526 |
| 9 | detection of light stimulus involved in visual perception (GO:0050908) | 4.17895526 |
| 10 | tolerance induction (GO:0002507) | 3.94871403 |
| 11 | base-excision repair, AP site formation (GO:0006285) | 3.85534976 |
| 12 | interferon-gamma production (GO:0032609) | 3.79393901 |
| 13 | regulation of protein kinase A signaling (GO:0010738) | 3.77929061 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.77778927 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 3.77778927 |
| 16 | positive regulation of humoral immune response (GO:0002922) | 3.52107938 |
| 17 | cellular response to ATP (GO:0071318) | 3.51733860 |
| 18 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.47863690 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.47518047 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.47518047 |
| 21 | positive regulation of defense response to virus by host (GO:0002230) | 3.32515986 |
| 22 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.28055865 |
| 23 | piRNA metabolic process (GO:0034587) | 3.28032448 |
| 24 | cAMP catabolic process (GO:0006198) | 3.26894069 |
| 25 | protein neddylation (GO:0045116) | 3.26720126 |
| 26 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.25714662 |
| 27 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.24979557 |
| 28 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.19502536 |
| 29 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.16296934 |
| 30 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.16296934 |
| 31 | gonadal mesoderm development (GO:0007506) | 3.15361795 |
| 32 | mast cell activation (GO:0045576) | 3.14618821 |
| 33 | lymph node development (GO:0048535) | 3.08173655 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05210480 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03257101 |
| 36 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.03000762 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.99950997 |
| 38 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.98001696 |
| 39 | platelet dense granule organization (GO:0060155) | 2.97587414 |
| 40 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.97178560 |
| 41 | one-carbon compound transport (GO:0019755) | 2.95973417 |
| 42 | cyclic nucleotide catabolic process (GO:0009214) | 2.95703413 |
| 43 | response to interleukin-15 (GO:0070672) | 2.94944798 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94862842 |
| 45 | peptidyl-histidine modification (GO:0018202) | 2.91835306 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91608880 |
| 47 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.88896425 |
| 48 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.88896425 |
| 49 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.88896425 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86086198 |
| 51 | pseudouridine synthesis (GO:0001522) | 2.86041912 |
| 52 | adenosine metabolic process (GO:0046085) | 2.85155000 |
| 53 | cellular response to exogenous dsRNA (GO:0071360) | 2.84199613 |
| 54 | GTP biosynthetic process (GO:0006183) | 2.83981783 |
| 55 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.83239276 |
| 56 | DNA methylation involved in gamete generation (GO:0043046) | 2.82758121 |
| 57 | tRNA processing (GO:0008033) | 2.82654391 |
| 58 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.80527382 |
| 59 | adaptation of signaling pathway (GO:0023058) | 2.79903616 |
| 60 | kynurenine metabolic process (GO:0070189) | 2.77800177 |
| 61 | mannosylation (GO:0097502) | 2.77020935 |
| 62 | respiratory electron transport chain (GO:0022904) | 2.76524322 |
| 63 | regulation of hypersensitivity (GO:0002883) | 2.76393536 |
| 64 | behavioral response to nicotine (GO:0035095) | 2.75040537 |
| 65 | magnesium ion transport (GO:0015693) | 2.74504411 |
| 66 | electron transport chain (GO:0022900) | 2.73923339 |
| 67 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.73757998 |
| 68 | negative T cell selection (GO:0043383) | 2.72879762 |
| 69 | protein complex biogenesis (GO:0070271) | 2.69949686 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 2.69728784 |
| 71 | negative regulation of telomere maintenance (GO:0032205) | 2.69627214 |
| 72 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.66515037 |
| 73 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.65557127 |
| 74 | maturation of 5.8S rRNA (GO:0000460) | 2.63681893 |
| 75 | hydrogen ion transmembrane transport (GO:1902600) | 2.63009491 |
| 76 | NADH dehydrogenase complex assembly (GO:0010257) | 2.62000669 |
| 77 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.62000669 |
| 78 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.62000669 |
| 79 | proton transport (GO:0015992) | 2.61909648 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 2.60972865 |
| 81 | hydrogen transport (GO:0006818) | 2.60590214 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60442575 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.59846889 |
| 84 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.57320786 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56220943 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 2.55908194 |
| 87 | GPI anchor metabolic process (GO:0006505) | 2.55559168 |
| 88 | mast cell degranulation (GO:0043303) | 2.55124080 |
| 89 | mast cell activation involved in immune response (GO:0002279) | 2.55124080 |
| 90 | cytidine deamination (GO:0009972) | 2.52419065 |
| 91 | cytidine metabolic process (GO:0046087) | 2.52419065 |
| 92 | cytidine catabolic process (GO:0006216) | 2.52419065 |
| 93 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52308677 |
| 94 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.51330549 |
| 95 | inositol phosphate dephosphorylation (GO:0046855) | 2.51330549 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.51299020 |
| 97 | T cell differentiation involved in immune response (GO:0002292) | 2.50520160 |
| 98 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.50520160 |
| 99 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.50520160 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50130273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.39394329 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.03104549 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96849483 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.89102884 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.82367876 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.81715349 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61336529 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.46439470 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45320439 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.36033019 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30727603 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.28980047 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.25264324 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22517485 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12965665 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07909227 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.05804664 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.83315288 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 1.81884891 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81040452 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80281504 |
| 22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76601214 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.75585646 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72707449 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.70114204 |
| 26 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.67165318 |
| 27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.66582186 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64424914 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62576821 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62207825 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58040379 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57285382 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56964285 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55844533 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53942707 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51869140 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.49010267 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46815679 |
| 39 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.46062533 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43804983 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41239606 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40516182 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40204718 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39452252 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38322153 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37751637 |
| 47 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37549846 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36227184 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33617338 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.28761980 |
| 51 | NCOR_22424771_ChIP-Seq_293T_Human | 1.27575794 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27259070 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23691802 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.23530899 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22184059 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21657548 |
| 57 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.20621941 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19785585 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19498963 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17665696 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17665696 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.15776188 |
| 63 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.14907401 |
| 64 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14124658 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12062476 |
| 66 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11949020 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11257465 |
| 68 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.11236193 |
| 69 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10086154 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09153323 |
| 71 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08459811 |
| 72 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08049590 |
| 73 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07217138 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06861484 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.06791494 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06494348 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06494348 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06240611 |
| 79 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05481675 |
| 80 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.04025033 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04014491 |
| 82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.03048728 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02960997 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02679125 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02050476 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01032647 |
| 87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00651971 |
| 88 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99835327 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99331316 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99049774 |
| 91 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98347292 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98295857 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98219411 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97907884 |
| 95 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97469847 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97420167 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96150611 |
| 98 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95883202 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94896549 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94253134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 3.41784272 |
| 2 | MP0005671_abnormal_response_to | 3.22448325 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.82012682 |
| 4 | MP0008872_abnormal_physiological_respon | 2.41458734 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.25453191 |
| 6 | MP0003787_abnormal_imprinting | 2.22514231 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.14813069 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10820654 |
| 9 | MP0003436_decreased_susceptibility_to | 2.10475505 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.07898035 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.05576871 |
| 12 | MP0001800_abnormal_humoral_immune | 2.03982413 |
| 13 | MP0000685_abnormal_immune_system | 2.03787756 |
| 14 | MP0001986_abnormal_taste_sensitivity | 1.98592729 |
| 15 | MP0008995_early_reproductive_senescence | 1.97520931 |
| 16 | MP0009785_altered_susceptibility_to | 1.96631966 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.90471592 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.89824907 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.87939179 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 1.85121928 |
| 21 | MP0003195_calcinosis | 1.84687439 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 1.84447778 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.74527571 |
| 24 | MP0002723_abnormal_immune_serum | 1.72446925 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.69533488 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.69481650 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 1.65744875 |
| 28 | MP0003786_premature_aging | 1.64300321 |
| 29 | MP0002163_abnormal_gland_morphology | 1.59759592 |
| 30 | MP0001529_abnormal_vocalization | 1.56654539 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.55679686 |
| 32 | MP0009764_decreased_sensitivity_to | 1.53410063 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.53168536 |
| 34 | MP0003252_abnormal_bile_duct | 1.49627646 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.48499121 |
| 36 | MP0001819_abnormal_immune_cell | 1.48414259 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.48324767 |
| 38 | MP0004043_abnormal_pH_regulation | 1.44715554 |
| 39 | MP0005387_immune_system_phenotype | 1.42222396 |
| 40 | MP0001790_abnormal_immune_system | 1.42222396 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.37159863 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.36866786 |
| 43 | MP0001727_abnormal_embryo_implantation | 1.35099049 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.33503295 |
| 45 | MP0003878_abnormal_ear_physiology | 1.33503295 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.32440272 |
| 47 | MP0000427_abnormal_hair_cycle | 1.32329355 |
| 48 | MP0003122_maternal_imprinting | 1.30393653 |
| 49 | MP0003011_delayed_dark_adaptation | 1.28506579 |
| 50 | MP0009046_muscle_twitch | 1.26059343 |
| 51 | MP0009745_abnormal_behavioral_response | 1.23574284 |
| 52 | MP0005025_abnormal_response_to | 1.23428004 |
| 53 | MP0005332_abnormal_amino_acid | 1.22077897 |
| 54 | MP0002102_abnormal_ear_morphology | 1.21658553 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.21465904 |
| 56 | MP0002693_abnormal_pancreas_physiology | 1.20470415 |
| 57 | MP0002272_abnormal_nervous_system | 1.19653890 |
| 58 | MP0005253_abnormal_eye_physiology | 1.19611091 |
| 59 | MP0003866_abnormal_defecation | 1.18353287 |
| 60 | MP0004484_altered_response_of | 1.16742392 |
| 61 | MP0005365_abnormal_bile_salt | 1.16178570 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.15586352 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.15079861 |
| 64 | MP0000716_abnormal_immune_system | 1.13158180 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.12839937 |
| 66 | MP0002405_respiratory_system_inflammati | 1.07971149 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.07003827 |
| 68 | MP0003724_increased_susceptibility_to | 1.06499057 |
| 69 | MP0003121_genomic_imprinting | 1.06120713 |
| 70 | MP0004142_abnormal_muscle_tone | 1.04162129 |
| 71 | MP0001873_stomach_inflammation | 1.02916360 |
| 72 | MP0002419_abnormal_innate_immunity | 1.02043290 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.01880385 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.00482634 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.99529268 |
| 76 | MP0004885_abnormal_endolymph | 0.98801371 |
| 77 | MP0002398_abnormal_bone_marrow | 0.98489603 |
| 78 | MP0003879_abnormal_hair_cell | 0.96826599 |
| 79 | MP0003186_abnormal_redox_activity | 0.96507509 |
| 80 | MP0001919_abnormal_reproductive_system | 0.96213430 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.95979470 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.92530450 |
| 83 | MP0001533_abnormal_skeleton_physiology | 0.88711234 |
| 84 | MP0004147_increased_porphyrin_level | 0.88294693 |
| 85 | MP0002722_abnormal_immune_system | 0.87832266 |
| 86 | MP0001905_abnormal_dopamine_level | 0.87533739 |
| 87 | MP0004381_abnormal_hair_follicle | 0.87023823 |
| 88 | MP0004742_abnormal_vestibular_system | 0.86682160 |
| 89 | MP0004924_abnormal_behavior | 0.85453903 |
| 90 | MP0005386_behavior/neurological_phenoty | 0.85453903 |
| 91 | MP0002429_abnormal_blood_cell | 0.85289198 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.83993091 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.82979271 |
| 94 | MP0005165_increased_susceptibility_to | 0.82696109 |
| 95 | MP0005389_reproductive_system_phenotype | 0.80679516 |
| 96 | MP0002572_abnormal_emotion/affect_behav | 0.80424773 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.80301129 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.79682993 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.77802971 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.76083997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.05951706 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.77632187 |
| 3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.75256960 |
| 4 | Hypoplasia of the fovea (HP:0007750) | 4.75256960 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.24291188 |
| 6 | Abnormality of the fovea (HP:0000493) | 4.08803315 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 3.76363134 |
| 8 | Severe visual impairment (HP:0001141) | 3.53128972 |
| 9 | Albinism (HP:0001022) | 3.44423108 |
| 10 | Agitation (HP:0000713) | 3.37334463 |
| 11 | Renal cortical cysts (HP:0000803) | 3.28228230 |
| 12 | Type II lissencephaly (HP:0007260) | 3.27031906 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 3.25209971 |
| 14 | IgG deficiency (HP:0004315) | 3.21503678 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.15864069 |
| 16 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.93841416 |
| 17 | Stomatitis (HP:0010280) | 2.92934014 |
| 18 | Central scotoma (HP:0000603) | 2.92815100 |
| 19 | Hepatic necrosis (HP:0002605) | 2.81278984 |
| 20 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79528801 |
| 21 | Abnormality of the renal cortex (HP:0011035) | 2.77986799 |
| 22 | Congenital, generalized hypertrichosis (HP:0004540) | 2.77836968 |
| 23 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.76646818 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.74135144 |
| 25 | Mitochondrial inheritance (HP:0001427) | 2.73946777 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73594669 |
| 27 | Increased CSF lactate (HP:0002490) | 2.69185444 |
| 28 | Molar tooth sign on MRI (HP:0002419) | 2.68099020 |
| 29 | Abnormality of midbrain morphology (HP:0002418) | 2.68099020 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65884413 |
| 31 | Opisthotonus (HP:0002179) | 2.58672227 |
| 32 | Acute encephalopathy (HP:0006846) | 2.58355330 |
| 33 | Progressive macrocephaly (HP:0004481) | 2.57467443 |
| 34 | Progressive microcephaly (HP:0000253) | 2.55407645 |
| 35 | Chronic diarrhea (HP:0002028) | 2.51959161 |
| 36 | Inability to walk (HP:0002540) | 2.50729415 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.48246342 |
| 38 | Abnormal number of erythroid precursors (HP:0012131) | 2.47717492 |
| 39 | Hypoproteinemia (HP:0003075) | 2.43076836 |
| 40 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.43038236 |
| 41 | Combined immunodeficiency (HP:0005387) | 2.42642532 |
| 42 | Thyroiditis (HP:0100646) | 2.41795453 |
| 43 | Nephronophthisis (HP:0000090) | 2.41505536 |
| 44 | Retinal dysplasia (HP:0007973) | 2.41504638 |
| 45 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31924576 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31924576 |
| 47 | Optic disc pallor (HP:0000543) | 2.30279297 |
| 48 | Cerebral hypomyelination (HP:0006808) | 2.27913322 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.26716128 |
| 50 | Hypoalbuminemia (HP:0003073) | 2.26278062 |
| 51 | Abnormal albumin level (HP:0012116) | 2.26278062 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.25544493 |
| 53 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17093211 |
| 54 | Mesangial abnormality (HP:0001966) | 2.15976954 |
| 55 | Scotoma (HP:0000575) | 2.08936440 |
| 56 | Prostate neoplasm (HP:0100787) | 2.08935140 |
| 57 | Progressive inability to walk (HP:0002505) | 2.05479391 |
| 58 | Abnormality of T cells (HP:0002843) | 2.04097436 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.04044815 |
| 60 | Polydipsia (HP:0001959) | 2.04044815 |
| 61 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.02400293 |
| 62 | T lymphocytopenia (HP:0005403) | 2.01687624 |
| 63 | Generalized hypopigmentation (HP:0007513) | 2.00928332 |
| 64 | Myositis (HP:0100614) | 1.98391338 |
| 65 | Increased corneal curvature (HP:0100692) | 1.98323577 |
| 66 | Keratoconus (HP:0000563) | 1.98323577 |
| 67 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.97819658 |
| 68 | Severe muscular hypotonia (HP:0006829) | 1.96656743 |
| 69 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.95441989 |
| 70 | Abnormality of the prostate (HP:0008775) | 1.94930205 |
| 71 | Broad-based gait (HP:0002136) | 1.92300386 |
| 72 | Abnormality of the pons (HP:0007361) | 1.90767801 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89947978 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89947978 |
| 75 | Abnormality of T cell number (HP:0011839) | 1.89577830 |
| 76 | Ketosis (HP:0001946) | 1.88519851 |
| 77 | Increased serum lactate (HP:0002151) | 1.88395876 |
| 78 | Pustule (HP:0200039) | 1.88181811 |
| 79 | Abnormality of B cell number (HP:0010975) | 1.88045256 |
| 80 | Neonatal respiratory distress (HP:0002643) | 1.87817823 |
| 81 | B lymphocytopenia (HP:0010976) | 1.86615794 |
| 82 | Lactic acidosis (HP:0003128) | 1.85765261 |
| 83 | Hypomagnesemia (HP:0002917) | 1.82567526 |
| 84 | Abnormality of the renal medulla (HP:0100957) | 1.82068539 |
| 85 | Hypothermia (HP:0002045) | 1.81862877 |
| 86 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81047312 |
| 87 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80447188 |
| 88 | Pancreatic cysts (HP:0001737) | 1.80195107 |
| 89 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78447096 |
| 90 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78447096 |
| 91 | Tubular atrophy (HP:0000092) | 1.78131210 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 1.77359893 |
| 93 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76468105 |
| 94 | Methylmalonic acidemia (HP:0002912) | 1.75625776 |
| 95 | Limb dystonia (HP:0002451) | 1.75173176 |
| 96 | Restlessness (HP:0000711) | 1.74758178 |
| 97 | Pachygyria (HP:0001302) | 1.74314776 |
| 98 | Oligomenorrhea (HP:0000876) | 1.73133256 |
| 99 | Tongue fasciculations (HP:0001308) | 1.71426288 |
| 100 | Polyuria (HP:0000103) | 1.70458241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.73446439 |
| 2 | MAP4K2 | 4.50301851 |
| 3 | VRK2 | 2.85462097 |
| 4 | TLK1 | 2.79318976 |
| 5 | WNK4 | 2.69872170 |
| 6 | TAOK3 | 2.49848581 |
| 7 | MUSK | 2.46130119 |
| 8 | NEK1 | 2.10225152 |
| 9 | ADRBK2 | 2.10115878 |
| 10 | NUAK1 | 2.04666049 |
| 11 | FRK | 2.00841060 |
| 12 | PINK1 | 1.94450502 |
| 13 | TSSK6 | 1.86355531 |
| 14 | IKBKE | 1.78289021 |
| 15 | GRK6 | 1.72283197 |
| 16 | CSNK1G3 | 1.67178347 |
| 17 | EIF2AK3 | 1.64984827 |
| 18 | GRK1 | 1.61677560 |
| 19 | TESK2 | 1.60287928 |
| 20 | CSNK1G2 | 1.53981229 |
| 21 | IKBKB | 1.49334828 |
| 22 | KIT | 1.47793601 |
| 23 | CSNK1A1L | 1.45696818 |
| 24 | PHKG1 | 1.44508092 |
| 25 | PHKG2 | 1.44508092 |
| 26 | BCKDK | 1.38108449 |
| 27 | MAP3K14 | 1.30718132 |
| 28 | GRK7 | 1.28943204 |
| 29 | CSNK1G1 | 1.27987184 |
| 30 | ZAK | 1.22458785 |
| 31 | WNK3 | 1.22361471 |
| 32 | SCYL2 | 1.21202042 |
| 33 | TEC | 1.19354423 |
| 34 | TRPM7 | 1.19184839 |
| 35 | MAP4K1 | 1.14946873 |
| 36 | CAMKK2 | 1.12105654 |
| 37 | SIK2 | 1.11432978 |
| 38 | OXSR1 | 1.11299716 |
| 39 | MAP3K12 | 1.08111115 |
| 40 | STK39 | 1.07942711 |
| 41 | MAP3K11 | 1.07595714 |
| 42 | ITK | 1.04695152 |
| 43 | MAP2K2 | 1.02458320 |
| 44 | SYK | 0.99454660 |
| 45 | TYK2 | 0.92019548 |
| 46 | EIF2AK2 | 0.90518611 |
| 47 | MAPKAPK5 | 0.90041128 |
| 48 | TBK1 | 0.88554320 |
| 49 | MAPKAPK3 | 0.87964910 |
| 50 | PAK3 | 0.87267768 |
| 51 | JAK1 | 0.77133880 |
| 52 | MAP3K13 | 0.76811596 |
| 53 | EPHA3 | 0.74844844 |
| 54 | PRKCQ | 0.73744328 |
| 55 | PTK2B | 0.72395141 |
| 56 | CSF1R | 0.71797225 |
| 57 | DAPK2 | 0.71649137 |
| 58 | VRK1 | 0.70274384 |
| 59 | BTK | 0.69041836 |
| 60 | DAPK1 | 0.68257065 |
| 61 | ALK | 0.67796963 |
| 62 | LCK | 0.67122868 |
| 63 | ADRBK1 | 0.66485820 |
| 64 | TAF1 | 0.65203395 |
| 65 | JAK3 | 0.64536504 |
| 66 | GRK5 | 0.62012525 |
| 67 | MAP2K6 | 0.60378854 |
| 68 | HCK | 0.59190295 |
| 69 | PLK2 | 0.59059049 |
| 70 | LYN | 0.55801171 |
| 71 | ATR | 0.55626949 |
| 72 | MYLK | 0.53616126 |
| 73 | LIMK1 | 0.53543005 |
| 74 | CCNB1 | 0.53446086 |
| 75 | NLK | 0.53411617 |
| 76 | STK38L | 0.49177344 |
| 77 | ILK | 0.47615395 |
| 78 | MST4 | 0.46436774 |
| 79 | MAP3K4 | 0.45513602 |
| 80 | CAMK2D | 0.45385817 |
| 81 | ERBB3 | 0.44216714 |
| 82 | CHUK | 0.43922319 |
| 83 | ARAF | 0.41983626 |
| 84 | IGF1R | 0.41042105 |
| 85 | FES | 0.41037121 |
| 86 | INSRR | 0.41009998 |
| 87 | CSNK1A1 | 0.40496554 |
| 88 | MAPK13 | 0.40056499 |
| 89 | HIPK2 | 0.39543718 |
| 90 | PASK | 0.39329292 |
| 91 | PRKCE | 0.38219642 |
| 92 | TGFBR2 | 0.36804089 |
| 93 | ZAP70 | 0.36679364 |
| 94 | EPHA4 | 0.36092197 |
| 95 | NTRK3 | 0.35811654 |
| 96 | MATK | 0.35713605 |
| 97 | ABL2 | 0.34332323 |
| 98 | PRKACA | 0.33954987 |
| 99 | MARK3 | 0.32119484 |
| 100 | CSNK1D | 0.31825251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.35231624 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.80049132 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.72379000 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.51718154 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.39772409 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.29421327 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.27078490 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15374512 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.14929747 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06304366 |
| 11 | Protein export_Homo sapiens_hsa03060 | 1.97369628 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97052706 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95583071 |
| 14 | RNA degradation_Homo sapiens_hsa03018 | 1.83148997 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.76482053 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74886365 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68609957 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57196303 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55653925 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54184383 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.54180728 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.53788167 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53442164 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.53165552 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51695123 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46079939 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.42849901 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41859335 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40193673 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38381865 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.38114125 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36085780 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.33922247 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.23275441 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22483688 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21907053 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20364376 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19692442 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.18881512 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16642360 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.14586926 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09114175 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.08765630 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.07037365 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.06943292 |
| 46 | GABAergic synapse_Homo sapiens_hsa04727 | 1.04933573 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01063054 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99517693 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97024066 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96917103 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96796371 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.94933026 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92998966 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91724154 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87003481 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84795106 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83405993 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81223634 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81010964 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80732936 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79196314 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77578109 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76573038 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.75288154 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.70735623 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70647057 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70125305 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.67919577 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67184569 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66633309 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65844827 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.64056710 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62859905 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62262921 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61516709 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59833221 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59463426 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55138876 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54198343 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.54196635 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53874598 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52038377 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50188331 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.47306475 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45942049 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45808976 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45674104 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45450349 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44860674 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44749178 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44000161 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43316428 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.42668872 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42260696 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40316326 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39134765 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39091884 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39082646 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.36682124 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.36351773 |

